Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Women who use drugs, harm reduction and HIV
This issue brief about HIV, harm reduction and the sexual and reproductive health and rights of women who use drugs is part of a series of brie"ng papers, commissioned by the Global Coalition on Women and AIDS (GCWA). It focuses on "the gendered nature of elevated risk" and gives recommendations.
This issue brief about HIV, harm reduction and the sexual and reproductive health and rights of women who use drugs is part of a series of brie"ng papers, commissioned by the Global Coalition on Women and AIDS (GCWA). It focuses on "the gendered nature of elevated risk" and gives recommendations.
Peace, Drug Policy, and an Inclusive Society
Eleven Ways Colombian and FARC Negotiators can Reform Drug Policy and Build a Lasting Peace: recommendations written by WOLA outline 11 elements of a more effective and humane approach to drug policy.
Eleven Ways Colombian and FARC Negotiators can Reform Drug Policy and Build a Lasting Peace: recommendations written by WOLA outline 11 elements of a more effective and humane approach to drug policy.
What is Harm Reduction?
Open Society Foundation give a great explainer of harm reduction, stating that it is a multi-faceted and the importance of changing drug policy.
Open Society Foundation give a great explainer of harm reduction, stating that it is a multi-faceted and the importance of changing drug policy.
IDHDP November / December 2013
This issue of the the IDHDP newsletter highlights: IDHDP plenary session: Policy, Society, Alcohol and Novelty in Addiction |International Drug Policy Consortium ("IDPC") | Interviews and speeches | New publications on the website | Upcoming events | IDHDP communications
This issue of the the IDHDP newsletter highlights: IDHDP plenary session: Policy, Society, Alcohol and Novelty in Addiction |International Drug Policy Consortium ("IDPC") | Interviews and speeches | New publications on the website | Upcoming events | IDHDP communications
Hepatitis Scotland e-Bulletin: A Treatment Focus
Hepatitis Scotland review recent treatment news, including research presented at the 64th Annual Meeting of the American Association for the Study of the Liver in Washington D.C, along with other stories relevant to the treatment of viral hepatitis. Highlighting a way forward without inteferon but looks like the cost will exclude 90% of people who need them.
Hepatitis Scotland review recent treatment news, including research presented at the 64th Annual Meeting of the American Association for the Study of the Liver in Washington D.C, along with other stories relevant to the treatment of viral hepatitis. Highlighting a way forward without inteferon but looks like the cost will exclude 90% of people who need them.
Palliative care – a human right
The European Association for Palliative Care, the International Association for Hospice and Palliative care, the Worldwide Palliative Care Alliance and the Human Rights Watch, urge governments to relieve suffering and recognize palliative care as a human right. The briefing gives and definition of palliative care and state what the groups would like governments to recognize the need for access to palliative care.
The European Association for Palliative Care, the International Association for Hospice and Palliative care, the Worldwide Palliative Care Alliance and the Human Rights Watch, urge governments to relieve suffering and recognize palliative care as a human right. The briefing gives and definition of palliative care and state what the groups would like governments to recognize the need for access to palliative care.
The war in Syria and the drug bomb
Dr. Ghassan Shahrour presentation at the MENA 2nd Conference held in Beirut November 2013 which discussed the regional drug maps.
Dr. Ghassan Shahrour presentation at the MENA 2nd Conference held in Beirut November 2013 which discussed the regional drug maps.
21–22 November 2013, Tallinn
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs
Annals of Oncology
Read ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world’s population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain. The GOPI study has uncovered a pandemic of over-regulation in much of the developing world that is making it catastrophically difficult to provide basic medication to relieve strong cancer pain,”
Read ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world’s population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain. The GOPI study has uncovered a pandemic of over-regulation in much of the developing world that is making it catastrophically difficult to provide basic medication to relieve strong cancer pain,”
Drug policy advocacy in Asia: Challenges, opportunities and prospects
International Drug Policy Consortium (IDPC), produced this report to develop a better understanding of drug policy advocacy activity in 10 Asian countries: Cambodia, China, India, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Thailand, and Vietnam. It aims to achieve three goals: 1; Identify organisations engaged in harm reduction and drug policy advocacy, 2;Identify gaps and challenges in harm reduction and drug policy advocacy that remain to be addressed, 3; Develop recommendations for prioritising new activities in harm reduction and drug policy advocacy.
International Drug Policy Consortium (IDPC), produced this report to develop a better understanding of drug policy advocacy activity in 10 Asian countries: Cambodia, China, India, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Thailand, and Vietnam. It aims to achieve three goals: 1; Identify organisations engaged in harm reduction and drug policy advocacy, 2;Identify gaps and challenges in harm reduction and drug policy advocacy that remain to be addressed, 3; Develop recommendations for prioritising new activities in harm reduction and drug policy advocacy.
